Joint Formulary & PAD

Mometasone furoate with olopatadine - Allergic rhinitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Nasal spray
Associated Icons :
Restrictions / Comments :
Important
Reserved for use where monotherapy is inadequate. Not 1st line.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Mometasone furoate with olopatadine
Indication :
Allergic rhinitis
Group Name :
Keywords :
Hay fever, hayfever, antihistamines, nasal sprays, allergy, seasonal allergic rhinitis, pollen allergy, intranasal corticosteroids, INCS
Brand Names Include :
Ryaltris
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Mometasone furoate with olopatadine is used to treat.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

To be used  as a 3rd line alternative when monotherapy is inadequate.